UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | -0.05 | -0.05 |
| Q1 2022 | 2022-05-04 | -0.05 | -0.05 |
| Q4 2021 | 2022-03-07 | -0.03 | -0.03 |
| Q3 2021 | 2021-11-02 | -0.04 | -0.04 |
| Q2 2021 | 2021-07-29 | -0.04 | -0.04 |
| Q1 2021 | 2021-05-04 | -0.05 | -0.05 |
| Q4 2020 | 2021-03-04 | 0.02 | 0.02 |
| Q3 2020 | 2020-11-02 | -0.05 | -0.05 |
| Q2 2020 | 2020-08-03 | 0.07 | 0.07 |
| 2016-07-06 | Reiterated Rating | Rodman & Renshaw | Buy | $4.00 |
| 2016-05-13 | Reiterated Rating | Rodman & Renshaw | Buy | $4.00 |
| 2016-04-25 | Initiated Coverage | Rodman & Renshaw | Buy | $4.00 |
| 2015-07-17 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2015-06-23 | Reiterated Rating | Cantor Fitzgerald | Buy | $3.00 |
| 2015-05-01 | Boost Price Target | Cantor Fitzgerald | Buy | $2.50 to $3.00 |
| 2015-05-01 | Boost Price Target | Stifel Nicolaus | Buy | $1.50 to $2.50 |
| 2015-04-22 | Reiterated Rating | Cantor Fitzgerald | Buy | $2.50 |
| 2015-03-13 | Boost Price Target | Cantor Fitzgerald | Buy | $2.00 to $2.50 |
| 2015-03-03 | Upgrade | Cantor Fitzgerald | Hold to Buy | $1.00 to $2.00 |
| 2014-12-16 | Initiated Coverage | Cantor Fitzgerald | Hold | $1.00 |
| 2014-10-28 | Reiterated Rating | Stifel Nicolaus | Buy | $2.50 to $1.50 |
| 2012-11-01 | Downgrade | C.K. Cooper | Buy to Hold | $3 |
| 2012-08-17 | Initiated | C.K. Cooper | Buy | $3 |
| 2009-06-23 | Initiated | Caris & Company | Buy | $5 |
| 2008-03-18 | Initiated | Punk, Ziegel & Co | Mkt Perform | $5 |
| 2007-09-20 | Initiated | Broadpoint Capital | Strong Buy | $10.25 |
| 2016-07-06 | Reiterated Rating | Rodman & Renshaw | Buy | $4.00 |
| 2016-05-13 | Reiterated Rating | Rodman & Renshaw | Buy | $4.00 |
| 2016-04-25 | Initiated Coverage | Rodman & Renshaw | Buy | $4.00 |
| 2015-07-17 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2015-06-23 | Reiterated Rating | Cantor Fitzgerald | Buy | $3.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In DRRX 66 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 10.24M |
| INGALLS & SNYDER LLC | 9.12M |
| BlackRock Institutional Trust Company, N.A. | 4.14M |
| BlackRock Fund Advisors | 4.03M |
| RENAISSANCE TECHNOLOGIES LLC | 3.45M |
| BlackRock Inc. | 2.91M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.05M |
| GAGNON SECURITIES LLC | 1.48M |
| HARBERT FUND ADVISORS, INC. | 1.27M |
| ZESIGER CAPITAL GROUP LLC | 0.90M |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.87M |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 0.85M |
| KINGS POINT CAPITAL MANAGEMENT | 0.82M |
| STATE STREET CORP | 0.77M |
| Dalton Investments LLC | 0.75M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| 21 APRIL FUND LTD | 12.89% (14381546) | DRRX / INVE / IVAC / |
| THEEUWES FELIX Chairman and CSO | 2.99% (3331814) | DRRX / |
| LIU JEAN I Sr. VP & General Counsel | 0.17% (184627) | DRRX / HALO / SGEN / |
| HOFFMANN DAVE | 0.11% (120000) | DRRX / THLD / |
| BENITO SIMON X | 0.08% (85000) | DRRX / INO / |
| YUM SU IL Exec. VP Pharm./R&D | 0.07% (73454) | DRRX / |
| BROWN JAMES E President & CEO | 0.05% (52100) | DRRX / |
| Neukermans Armand | 0.03% (36400) | DRRX / |
| Blaschke Terrence F | 0.03% (28000) | DRRX / |
| SAXE JON S | 0.02% (27810) | DRRX / PDLI / SCLN / VTGN / |
UM